This is the authors' abstract. We don't add key points for this paper.
In recent years, cell-free extracts (or lysates) have (re-)emerged as a third route to the traditional options of isolated or whole-cell biocatalysts. Advances in molecular biology and genetic engineering enable facile production of recombinant cell-free extracts, where endogenous enzymes are enriched with heterologous activities. These inexpensive preparations may be used to catalyse multistep enzymatic reactions without the constraints of cell toxicity and the cell membrane or the cost and complexity associated with production of isolated biocatalysts. Herein, we present an overview of the key advancements in cell-free synthetic biology that have led to the emergence of cell-free extracts as a promising biocatalysis platform.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Apostolos Alissandratos (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: